Recce Pharmaceuticals Ltd

Recce Pharmaceuticals Ltdverified

RCE.AX

Price:

$0.475

Market Cap:

$110.14M

Recce Pharmaceuticals Ltd, a biotechnology company, engages in the research, development, and commercialization of synthetic anti–infectives in Australia, the United States, and the United Kingdom. The company's lead candidate is RECCE 327 to treat blood infections and sepsis derived from E. coli and S. aureus bacteria, including their superbug forms. It also develops RECCE 529, a synthetic anti-infective for viral infections; and RECCE 435, a synthetic polymer anti-infective. The company was formerly known as Recce Limited and changed its name to Recce Pharmaceuticals Ltd in November 2017. Recce Pharmaceuticals Ltd was incorporated in 2007 and is headquartered in Sydney, Australia.[Read more]

Industry

Biotechnology

IPO Date

2016-01-14

Stock Exchange

ASX

Ticker

RCE.AX

The Enterprise Value as of January 2025 (TTM) for Recce Pharmaceuticals Ltd (RCE.AX) is 106.54M

According to Recce Pharmaceuticals Ltd’s latest financial reports and current stock price. The company's current Enterprise Value is 106.54M. This represents a change of -2.57% compared to the average of 109.34M of the last 4 quarters.

Recce Pharmaceuticals Ltd (RCE.AX) Historical Enterprise Value (quarterly & annually)

How has RCE.AX Enterprise Value performed in the past?

The mean historical Enterprise Value of Recce Pharmaceuticals Ltd over the last ten years is 63.20M. The current 106.54M Enterprise Value has changed 16.76% with respect to the historical average. Over the past ten years (40 quarters), RCE.AX's Enterprise Value was at its highest in in the June 2022 quarter at 148.18M. The Enterprise Value was at its lowest in in the January 2015 quarter at 0.

Quarterly (TTM)
Annual

Average

63.20M

Median

52.16M

Minimum

5.10M

Maximum

145.02M

Recce Pharmaceuticals Ltd (RCE.AX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Recce Pharmaceuticals Ltd Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 300.42%

Maximum Annual Enterprise Value = 145.02M

Minimum Annual Increase = -5521.50%

Minimum Annual Enterprise Value = 5.10M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024102.66M-5.39%
2023108.51M-25.17%
2022145.02M15.81%
2021125.22M50.00%
202083.48M300.42%
201920.85M33.80%
201815.58M4.34%
201714.93M40.72%
201610.61M108.02%
20155.10M-5521.50%

Recce Pharmaceuticals Ltd (RCE.AX) Average Enterprise Value

How has RCE.AX Enterprise Value performed in the past?

The current Enterprise Value of Recce Pharmaceuticals Ltd (RCE.AX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

118.73M

5-year avg

112.98M

10-year avg

63.20M

Recce Pharmaceuticals Ltd (RCE.AX) Enterprise Value vs. Peers

How is RCE.AX’s Enterprise Value compared to its peers?

Recce Pharmaceuticals Ltd’s Enterprise Value is less than Orthocell Limited (320.45M), less than Race Oncology Limited (205.16M), less than Paradigm Biopharmaceuticals Limited (145.98M), less than Opthea Limited (538.10M), greater than Mach7 Technologies Limited (57.11M),

CompanyEnterprise ValueMarket cap
320.45M$340.38M
205.16M$222.35M
145.98M$163.56M
538.10M$923.44M
57.11M$82.02M

Build a custom stock screener for Recce Pharmaceuticals Ltd (RCE.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Recce Pharmaceuticals Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Recce Pharmaceuticals Ltd (RCE.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Recce Pharmaceuticals Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Recce Pharmaceuticals Ltd's Enterprise Value?

What is the highest Enterprise Value for Recce Pharmaceuticals Ltd (RCE.AX)?

What is the 3-year average Enterprise Value for Recce Pharmaceuticals Ltd (RCE.AX)?

What is the 5-year average Enterprise Value for Recce Pharmaceuticals Ltd (RCE.AX)?

How does the current Enterprise Value for Recce Pharmaceuticals Ltd (RCE.AX) compare to its historical average?